Background: The effectiveness of statin use in preventing adverse cardiovascular events in individuals with atrial fibrillation (AF) has remained uncertain. This study aimed to assess whether statin use could lead to better outcomes among individuals with AF.
Methods And Results: We enrolled 397 787 patients with AF from January 1, 2012 to December 31, 2020.
Electrochemistry-based wearable and wireless sweat analysis is emerging as a promising noninvasive method for real-time health monitoring by tracking chemical and biological markers without the need for invasive blood sampling. It offers the potential to remotely monitor human sweat conditions in relation to metabolic health, stress, and electrolyte balance, which have implications for athletes, patients with chronic conditions, and individuals for the early detection and management of health issues. The state-of-the-art mainstream technology is dominated by the concept of a wearable microfluidic chip, typically based on elastomeric PDMS.
View Article and Find Full Text PDF